Effects of nitrobenzylthioinosine on neuronal injury, adenosine levels, and adenosine receptor activity in rat forebrain ischemia

Journal of Neurochemistry

Volumn 75, Issue 2, 2000, Pages 795-802

  Parkinson, F E ^a   Zhang, Y W ^a   Shepel, P N ^a   Greenway, S C ^a   Peeling, J ^a   Geiger, J D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adenosine; Cerebral ischemia; Nitrobenzylthioinosine; Nucleoside transport; Tumor necrosis factor

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR; CYTOKINE; NITROBENZYLTHIOINOSINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; FOREBRAIN; HIPPOCAMPUS; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ADENOSINE; AFFINITY LABELS; ANIMALS; CEREBRAL VENTRICLES; GENE EXPRESSION REGULATION; INJECTIONS, INTRAVENTRICULAR; ISCHEMIC ATTACK, TRANSIENT; MALE; NEURONS; PRODRUGS; PROSENCEPHALON; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; REPERFUSION; THIOINOSINE; THIONUCLEOTIDES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0033940768     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750795.x     Document Type: Article

References (43)

1. Anderson C. M., Sitar D. S., and Parkinson F. E. (1996a) Ability of nitrobenzylthioinosine to cross the blood-brain barrier in rats. Neurosci. Lett. 219, 191-194.
2. Anderson C. M., Xiong W., Young J. D., Cass C. E., and Parkinson F. E. (1996b) Demonstration of the existence of mRNAs encoding the N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain. Mol. Brain Res. 42, 358-361.
3. Andiné P., Rudolphi K. A., Fredholm B. B., and Hagberg H. (1990) Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br. J. Pharmacol. 100, 814-818.
4. Borgland S. L., Castanon M., Spevak W., and Parkinson F. E. (1998) Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene. Can. J. Physiol. Pharmacol. 76, 1132-1138.
5. Campisi P., Carmichael F. J. L., Crawford M., Orrego H., and Khanna J. M. (1997) Role of adenosine in the ethanol-induced potentiation of the effects of general anesthetics in rats. Eur. J. Pharmacol. 325, 165-172.
6. Cass C. E. (1995) Nucleoside transport, in Drug Transport in Antimicrobial Therapy and Anticancer Therapy (Georgopapadakou N. H., ed), pp. 403-451. Marcel Dekker, New York.
7. Chen J.-F., Huang Z., Ma J., Zhu J. M., Moratalla R., Standaert D., Moskowitz M. A., Fink J. S., and Schwarzschild M. A. (1999) A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192-9200.
8. Clemens J. A., Stephenson D. T., Dixon E. P., Smalstig E. B., Mincy R. E., Rash K. S., and Little S. P. (1997) Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res. Mol. Brain Res. 48, 187-196.
9. Craig C. G. and White T. D. (1993) N-Methyl-D-aspartate- and non-N-methyl-D-aspartate-evoked adenosine release from rat cortical slices: distinct purinergic sources and mechanisms of release. J. Neurochem. 60, 1073-1080.
10. Delaney S. M. and Geiger J. D. (1996) Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation. J. Neurosci. Methods 64, 151-156.
11. Delaney S. M., Sutherland G. R., Peeling J., and Geiger J. D. (1993) Failure of 2′-deoxycoformycin to protect against transient fore-brain ischemia in rat. Neurosci. Lett. 149, 31-34.
12. DeLeo J., Schubert P., and Kreutzberg G. W. (1988) Propentofylline (HWA 285) protects hippocampal neurons of Mongolian gerbils against ischemic damage in the presence of an adenosine antagonist. Neurosci. Lett. 84, 307-311.
13. Dionyssopoulos T., Hope W., and Coupar I. M. (1992) Effect of adenosine analogues on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 42, 201-206.
14. Dirnagl U., Iadecola C., and Moskowitz M. A. (1999) Pathobiology of ischemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
15. Evans M. C., Swan J. H., and Meldrum B. S. (1987) An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci. Lett. 83, 287-292.
16. Fredholm B. B., Fastbom J., Kvanta A., Gerwins P., and Parkinson F. (1992) Further evidence that propentofylline (HWA 285) influences both adenosine receptors and adenosine transport. Fundam. Clin. Pharmacol. 6, 99-111.
17. Fredholm B. B., Lindström K., and Wallman-Johansson A. (1994) Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical or metabolic stimulation of rat hippocampal slices. J. Neurochem. 62, 563-573.
18. Gati W. P. and Paterson A. R. (1997) Measurement of nitrobenzylthioinosine in plasma and erythrocytes: a pharmacokinetic study in mice. Cancer Chemother. Pharmacol. 40, 342-346.
19. Georgiev V. P. and Tchekalarova J. D. (1998) Interaction of angiotensin II and adenosine receptors in pentylenetetrazol-induced kindling in mice. Brain Res. 779, 259-261.
20. Jacobson K. A., Park K. S., Jiang J. L., Kim Y. C., Olah M. E., Stiles G. L., and Ji X. D. (1997) Pharmacological characterization of novel A3 adenosine receptor-selective antagonists. Neuropharmacology 36, 1157-1165.
21. Mayne M., Shepel P. N., Jiang Y., Geiger J. D., and Power C. (1999) Dysregulation of adenosine Al receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients. Ann. Neurol. 45, 633-639.
22. 3H]adenosine influx: a study of three nucleoside transport systems. Biochem. Pharmacol. 46, 891-896.
23. Parkinson F. E., Rudolphi K. A., and Fredholm B. B. (1994) Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia. Gen. Pharmacol. 25, 1053-1058.
24. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
25. Phillis J. W. and O'Regan M. H. (1996) Effects of an inhibitor of adenosine deaminase, deoxycoformycin, and of nucleoside transport, propentofylline, on post-ischemic recovery of adenine nucleotides in rat brain. Neurochem. Res. 21, 347-353.
26. Phillis J. W., Smith Barbour M., and O'Regan M. H. (1996) Changes in extracellular amino acid neurotransmitters and purines during and following ischemias of different durations in the rat cerebral cortex. Neurochem. Int. 29, 115-120.
27. Rudolphi K. A., Schubert P., Parkinson F. E., and Fredholm B. B. (1992) Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13, 439-445.
28. Saito K., Suyama K., Nishida K., Sei Y., and Basile A. S. (1996) Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci. Lett. 206, 149-152.
29. Sajjadi F. G., Takabayashi K., Foster A. C., Domingo R. C., and Firestein G. S. (1996) Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J. Immunol. 156, 3435-3442.
30. Schubert P., Ogata T., Marchini C., Ferroni S., and Rudolphi K. (1997) Protective mechanisms of adenosine in neurons and glial cells. Ann. NY Acad. Sci. 825, 1-10.
31. 1 adenosine receptor activation. Biochem. Pharmacol. 59, 477-483.
32. Sutherland G. R., Peeling J., Lesiuk H. J., Brownstone R. M., Rydzy M., Saunders J. K., and Geiger J. D. (1991) The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology. Neuroscience 42, 171-182.
33. Sweeney M. I. (1997) Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci. Biobehav. Rev. 21, 207-217.
34. Uno H., Matsuyama T., Akita H., Nishimura H., and Sugita M. (1997) Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 17, 491-499.
35. Vertes R. P. and Wu P. H. (1985) Potent depressant effects of adenosine analogs on hippocampal slow-wave activity in the unanesthetized rat. Exp. Brain Res. 60, 48-53.
36. von Lubitz D. K. (1999) Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 371, 85-102.
37. von Lubitz D. K. and Marangos P. J. (1990) Cerebral ischemia in gerbils: postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophylline. J. Mol. Neurosci. 2, 53-59.
38. von Lubitz D. K., Dambrosia J. M., Kempski O., and Redmond D. J. (1988) Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus. Stroke 19, 1133-1139.
39. von Lubitz D. K., Dambrosia J. M., and Redmond D. J. (1989) Protective effect of cyclohexyl adenosine in treatment of cerebral ischemia in gerbils. Neuroscience 30, 451-462.
40. von Lubitz D. K., Lin R. C., Popik P., Carter M. F., and Jacobson K. A. (1994) Adenosine A3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263, 59-67.
41. Wagner D. R., Combes A., McTiernan C., Sanders V. J., Lemster B., and Feldman A. M. (1998) Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha. Circ. Res. 82, 47-56.
42. Wagner D. R., Kubota T., Sanders V. J., McTiernan C. F., and Feldman A. M. (1999) Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors. Am. J. Physiol. 276, H2141-H2147.
43. Westerberg V. S. and Geiger J. D. (1987) Central effects of adenosine analogs on stress-induced gastric ulcer formation. Life Sci. 41, 2201-2205.